Identification of the familial cylindromatosis tumour-suppressor gene
about
Deubiquitylating enzymes and diseaseTumor promoting or tumor suppressing of NF-kB, a matter of cell context dependencyStabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8The deubiquitinating enzyme CYLD controls apical docking of basal bodies in ciliated epithelial cellsThe tumor suppressor CYLD regulates entry into mitosisK63-specific deubiquitination by two JAMM/MPN+ complexes: BRISC-associated Brcc36 and proteasomal Poh1CYLD negatively regulates cell-cycle progression by inactivating HDAC6 and increasing the levels of acetylated tubulinThe tumour suppressor CYLD is a negative regulator of RIG-I-mediated antiviral responseUSP17 regulates Ras activation and cell proliferation by blocking RCE1 activityZinc-finger protein A20, a regulator of inflammation and cell survival, has de-ubiquitinating activityAgonist-promoted Lys63-linked polyubiquitination of the human kappa-opioid receptor is involved in receptor down-regulationThe de-ubiquitinase UCH-L1 is an oncogene that drives the development of lymphoma in vivo by deregulating PHLPP1 and Akt signalingDegradation of transcription repressor ZBRK1 through the ubiquitin-proteasome pathway relieves repression of Gadd45a upon DNA damageThe tumor suppressor CYLD interacts with TRIP and regulates negatively nuclear factor kappaB activation by tumor necrosis factorDUBs, New Members in the Hypoxia Signaling clUbTNF biology, pathogenic mechanisms and emerging therapeutic strategiesRegulation of Met1-linked polyubiquitin signalling by the deubiquitinase OTULINRegulation of NF-κB by ubiquitinationPKCθ/β and CYLD are antagonistic partners in the NFκB and NFAT transactivation pathways in primary mouse CD3+ T lymphocytesCrystal structure of the cytoskeleton-associated protein glycine-rich (CAP-Gly) domainMolecular basis for specificity of the Met1-linked polyubiquitin signalInhibition of 19S proteasome-associated deubiquitinases by metal-containing compoundsLinear ubiquitination in immunityCYLD Limits Lys63- and Met1-Linked Ubiquitin at Receptor Complexes to Regulate Innate Immune SignalingDUBA: a deubiquitinase that regulates type I interferon productionBiallelic hypomorphic mutations in a linear deubiquitinase define otulipenia, an early-onset autoinflammatory diseaseSignal transduction: aspirin, ubiquitin and cancerLoss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaBNF-kappaB-related genetic diseasesRegulation of T cell development by the deubiquitinating enzyme CYLDThe tumour suppressor CYLD regulates the p53 DNA damage responseThe ubiquitin-modifying enzyme A20 is required for termination of Toll-like receptor responsesLoss of heterozygosity at cylindromatosis gene locus, CYLD, in sporadic skin adnexal tumours.Brooke-Spiegler syndrome: treatment with laser ablation.Tumor suppressor CYLD acts as a negative regulator for non-typeable Haemophilus influenza-induced inflammation in the middle ear and lung of mice.The ubiquitin system, disease, and drug discovery.Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.Association of a de novo 16q copy number variant with a phenotype that overlaps with Lenz microphthalmia and Townes-Brocks syndromes.Regulation of the deubiquitinating enzyme CYLD by IkappaB kinase gamma-dependent phosphorylation.Specificity of the BRISC deubiquitinating enzyme is not due to selective binding to Lys63-linked polyubiquitin.
P2860
Q21284381-C6423724-060C-4ABF-BC4C-120B52C5FCA0Q23912835-C76D0D9F-6454-479B-B92A-3E950C76DDE8Q24301536-5854883A-1CDF-4AB1-AB51-44B51732E54FQ24302203-6B97B97F-E48D-4259-BEF0-16FE354C9D93Q24305326-AA1FE57B-32F0-4C23-B2E9-152D3FB70E6AQ24310641-469E2362-9C6B-4EF4-B7FE-079ECAFB16F3Q24314876-770BDF4E-F169-437D-94F3-CA3C4335BD3FQ24314946-E1CE2661-65F6-4EED-B671-74480A813082Q24328791-73C1250C-4718-4DA0-BA97-3294F512DC88Q24530708-FBC3EA01-DE6F-4B90-9DBD-A4C17982F4D3Q24618315-22D3BC22-707F-43AA-9AC1-B824AE7D2498Q24629152-6D489A9D-AEBE-447B-8DF0-8FF0318D315BQ24653338-7822531F-7F1B-46E2-A290-9B2314CE6EB3Q24672820-AA155A07-FB7B-49FE-A5BF-B3017DBDE736Q26750882-241DD742-90E0-4F6B-8702-ADBBAD013071Q26776492-24DAB031-AE57-4534-A6ED-4BE4461B66DCQ26778774-BDE5BDB2-6800-4F7D-8A2B-4FF228BDDE00Q27024099-CFAC5402-7F0C-4956-B2DB-B0E9514D742AQ27320965-CFC3D060-55AF-4261-AD45-F473C8F0A343Q27639629-B369DD02-0D40-4706-A370-874D4EB09459Q28072740-A39EA2C0-7F52-4FC5-B457-062176534F83Q28082497-EA386B59-3738-4872-B733-069DD4084272Q28082899-A4DB6E90-BF32-4479-B45D-8FA0234D8561Q28117541-776920DC-F55C-4FE2-8BD4-F72CB9BA83F5Q28118215-1E74CDE8-938E-4AFC-A99B-F138634E4FB3Q28119173-FAC13858-9FDE-4066-ABE2-1F9AA81D718EQ28199300-D4AA1ABE-0F44-4707-B32A-96D7CA1B575AQ28201706-4DED0E26-367A-485E-AFA3-1A7DAE8F428BQ28290224-A45117E0-4DBD-4983-8C95-1DC3C504207FQ28588773-705DA57E-3F10-4992-9A45-8B6E8D50DF77Q28828272-FCBA5D0B-48FE-4061-AF73-8AC140569155Q29616349-C3BE00B2-29C2-47C7-AFF8-F34275E9CE0AQ30708238-0D6948E0-A875-4D04-B97F-4A04BE5B9FF8Q33217003-A1FBD9B7-545F-4650-84F0-BDBE1B72CF57Q33302126-5739C7E8-2AF6-4E3B-BA5A-46A5327E1F7CQ33384295-85C4B714-F6D7-4B4C-A5F4-6E433CE6905BQ33456429-EB9DAD97-92E8-4B80-A975-AED6E97D4909Q33518062-5486D6E1-9FBA-4F98-89EA-553787118EB6Q33770420-F01BE8BC-2D39-4B6D-9E88-99DBE2BF8D68Q33796008-FFC85E60-BB35-4B20-B8B1-09CF734AB0DD
P2860
Identification of the familial cylindromatosis tumour-suppressor gene
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Identification of the familial cylindromatosis tumour-suppressor gene
@ast
Identification of the familial cylindromatosis tumour-suppressor gene
@en
Identification of the familial cylindromatosis tumour-suppressor gene
@nl
type
label
Identification of the familial cylindromatosis tumour-suppressor gene
@ast
Identification of the familial cylindromatosis tumour-suppressor gene
@en
Identification of the familial cylindromatosis tumour-suppressor gene
@nl
prefLabel
Identification of the familial cylindromatosis tumour-suppressor gene
@ast
Identification of the familial cylindromatosis tumour-suppressor gene
@en
Identification of the familial cylindromatosis tumour-suppressor gene
@nl
P2093
P50
P3181
P356
P1433
P1476
Identification of the familial cylindromatosis tumour-suppressor gene
@en
P2093
A van Den Ouweland
C Schrander-Stumpel
F A Beemer
G R Bignell
P2888
P304
P3181
P356
10.1038/76006
P407
P577
2000-06-01T00:00:00Z